pole3.comHealthcare / Medical DevicesFounded: 2014Funding to Date: $167.22MM
Third Pole Therapeutics is a biotechnology company that is developing and commercializing novel, portable inhaled nitric oxide (iNO) delivery systems for the treatment of pulmonary hypertension and other cardio-pulmonary diseases. The company's proprietary technology, known as the iNOvent™ platform, enables on-demand, targeted delivery of iNO to patients in a variety of settings, including hospitals, clinics, and homes. Third Pole Therapeutics aims to improve patient outcomes and quality of life by providing safe, effective, and accessible iNO therapy.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Third Pole Therapeutics.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.